Optimizing therapeutic efficacy of chemopreventive agents: A critical review of delivery strategies in oral cancer chemoprevention clinical trials.
about
Chemopreventive potential of flavonoids in oral squamous cell carcinoma in human studiesBiomarkers and chemopreventives in oral carcinogenesis and its preventionAdvanced drug delivery systems for local treatment of the oral cavityEvaluation of a mucoadhesive fenretinide patch for local intraoral delivery: a strategy to reintroduce fenretinide for oral cancer chemopreventionMucoadhesive fenretinide patches for site-specific chemoprevention of oral cancer: enhancement of oral mucosal permeation of fenretinide by coincorporation of propylene glycol and menthol.Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.Polymeric drug delivery systems for intraoral site-specific chemoprevention of oral cancer.Induction of Cell Cycle Arrest and Apoptotic Response of Head and Neck Squamous Carcinoma Cells (Detroit 562) by Caffeic Acid and Caffeic Acid Phenethyl Ester Derivative.Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system.
P2860
Q26824374-17A6051E-6309-4C0C-AA92-E5C33365BB44Q27025245-DDFBD345-77C5-4171-9556-206591ED857FQ28087186-AEC9A1C7-5B95-4B9E-8284-AE88C73C18B8Q35907443-A7453C09-79BF-4C17-8D66-F4D0F161FEA7Q36942385-5E7051FC-C113-4DDA-B9D6-8AA5C8000C7CQ37728618-F15D0637-DF0F-42E3-8003-E785C3AB198AQ39398234-E4520673-95CD-440E-9011-FD3FCE682A8EQ42327960-8E256FA8-AFB0-454D-B651-0512F88D282BQ51043354-02B09E52-87D4-41F0-A24E-FBB09F9F7DE7
P2860
Optimizing therapeutic efficacy of chemopreventive agents: A critical review of delivery strategies in oral cancer chemoprevention clinical trials.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Optimizing therapeutic efficac ...... emoprevention clinical trials.
@ast
Optimizing therapeutic efficac ...... emoprevention clinical trials.
@en
type
label
Optimizing therapeutic efficac ...... emoprevention clinical trials.
@ast
Optimizing therapeutic efficac ...... emoprevention clinical trials.
@en
prefLabel
Optimizing therapeutic efficac ...... emoprevention clinical trials.
@ast
Optimizing therapeutic efficac ...... emoprevention clinical trials.
@en
P2093
P2860
P356
P1476
Optimizing therapeutic efficac ...... hemoprevention clinical trials
@en
P2093
Andrew S Holpuch
Steven P Schwendeman
Susan R Mallery
P2860
P356
10.4103/1477-3163.85185
P407
P577
2011-09-21T00:00:00Z